Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial.
J Cancer Res Clin Oncol
; 146(10): 2651-2657, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32623573
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Neoplasms
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Cancer Res Clin Oncol
Year:
2020
Document type:
Article
Affiliation country:
China
Country of publication:
Germany